fbpx
Insight Conference
Clinical Psychologist & Research and Knowledge Exchange Associate

Dr. rer. nat. Max Wolff

MIND Foundation

Max Wolff is a psychologist and clinical researcher at the MIND Foundation. His research is concerned with processes of behavioral change and the psychological mechanisms underlying the efficacy of psychedelic-assisted treatments for mental disorders. As a psychotherapist he works with cognitive-behavioral, emotion-focused, and acceptance-based approaches. Max coordinates the MIND Foundation’s APT – Augmented Psychotherapy Training, and he is a committee member at the Mental Health Section within the MIND Members Association. He also works as a study therapist in the EPIsoDE study, a randomized-controlled trial investigating the safety and efficacy of psilocybin for treatment-resistant depression at the Central Institute of Mental Health in Mannheim, Germany, and Charité University Medicine Berlin. 

 

Future Events


Past Events

Augmented Psychotherapy Training Workshop

APT – Augmented Psychotherapy Training is an advanced 2-years training program for medical doct…

View Event
A Simple Conceptual Model of How Psychedelics Affect Psychological Flexibility (for Better or Worse)

Many benefits and some of the harms associated with psychedelic use are arguably due to these dru…

View Event
MHS – A Growing Network of Psychedelic Therapists and Co-Therapists

In our workshop we will show how we organize medical doctors, psychotherapists and complementary …

View Event

Conference Presentations

INSIGHT 2019: A Cognitive-Behavioral Perspective on Avoidance and Acceptance in Psychedelic Therapy
INSIGHT 2019: Panel: The Case for Cognitive-Behavioral Models in the Treatment with Psychedelic States

Insight Newsletter

Sign up to our newsletters and we’ll keep you up to date with everything to do with INSIGHT.




    Newsletter